Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Research Brief: Another Worker Contributes to Axon Stability
31 August 2009. Building a healthy axon, like erecting a skyscraper, takes a variety of workers and materials: the cytoskeletal elements that form the structure, the energy provided by mitochondria, and the participation of other organelles such as the endoplasmic reticulum (see ARF related news story). In a paper posted online by PNAS this week, scientists from the Chinese Academy of Sciences in Shanghai name a new construction worker to the crew. They found that multisynthase complex p43 (MSC p43) is required for the assembly of neurofilaments, which undergird axon stability.

First author Xiaodong Zhu, principal investigator Jiawei Zhou, and colleagues discovered that neurofilament-L interacts with the pro-inflammatory protein MSC p43 in a yeast two-hybrid screen. Overexpression of neurofilament-L caused the formation of MSC p43-positive aggregates. These data led them to characterize MSC p43’s role in neural development and function.

The protein is expressed in several parts of the CNS, including the ventral horn of the spinal cord and the hippocampus. MSC p43-null mice exhibited a variety of symptoms including lameness of the hind limbs and decreased motor activity on a rotarod test. They also had muscular atrophy and decreased innervation of muscle fibers by two months of age. When the scientists examined the axons in the lumbar ventral roots of two-month-old null mutants, they observed shrunken, collapsed structures. The knockout animals also had fewer myelinated axons than did wild-type mice.

Next, the scientists explored the effects of MSC p43 on neurofilament networks. Overexpression of the protein in SH-SYS5 neuroblastoma cells resulted in punctate aggregates containing neurofilaments, suggesting the network was disassembled. Using electron microscopy, Zhu and colleagues found that neurofilaments were disorganized, with fewer and shorter fibrils than normal, in axons from two-month-old MSC p43-null mice. The animals also showed a two- to threefold increase in neurofilament phosphorylation levels compared to wild-type littermates. Experiments with hippocampal neural cultures bore out the role of MSC p43 as a negative regulator of neurofilament phosphorylation. The altered phosphorylation in the null animals appeared to cause the disruption of the neurofilament network.

The authors suggested that the symptoms of the MSC p43-null mice are similar to those of one type of Charcot-Marie-Tooth disease, which also affects peripheral nerves. Mutations in neurofilament-L have been linked to this type 2D CMT (Mersiyanova et al., 2000). Zhou noted that accumulation of hyperphosphorylated neurofilament has been linked to other diseases, such as ALS (Rouleau et al., 1996) and Parkinson disease (Goldman et al., 1983). “It is likely that the dysfunction of MSC p43 may be relevant to neurological disorders besides CMT,” he wrote in an e-mail to ARF.—Amber Dance.

Reference:
Zhu X, Liu Y, Yin Y, Shao A, Zhang B, Kim S, Zhou J. MSC p43 required for axonal development in motor neurons. PNAS Early Edition. Abstract

 
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad